Journal: Molecular Pain
Article Title: KCC2 receptor upregulation potentiates antinociceptive effect of GABAAR agonist on remifentanil-induced hyperalgesia
doi: 10.1177/17448069221082880
Figure Lengend Snippet: Muscimol or CLP257 dose-dependently inhibits RIH. (A, B) PWMT were evaluated at −24 h (baseline) and 4 h, 8 h, 16 h and 24 h after remifentanil administration. Data were expressed as percent change from the baseline (mean ± SD) ( n = 6). (C, E) Bands of western blot for the expression of GABAAα2R or KCC2 at 24 h after remifentanil administration. (D, F) The fold change for the density of GABAAα2R or KCC2 normalized to the GAPDH level. Data were expressed as mean ± SD ( n = 4). ** p < 0.01 group C; # p < 0.05 or ## p < 0.01 versus group RI; $ p < 0.05 or $$ p < 0.01 versus group low; & p < 0.05 or && p < 0.01 versus group medium.
Article Snippet: Both muscimol (M1523, Sigma-Aldrich, St Louis, MO, USA, dissolved in 0.05 M HCl) and CLP257 (HY-110,143, MedChemExpress, Monmouth Junction, NJ, USA, dissolved in 1% DMSO) were intrathecally injected through intrathecal catheter.
Techniques: Western Blot, Expressing